Wire

Sign in to baba News

One account across the web, iPhone and Android — your subscription follows it.

or use an email code

By continuing you agree to the terms and privacy policy.

Search stories

Type at least two characters. Results come from every newsroom baba reads.

↑↓ to move · ↵ to open · esc to close

Sign in to baba News

Sign in to keep asking. News Plus removes the daily limit.

or use an email code

By continuing you agree to the terms and privacy policy.

Full coverage· Tech· Updated

Israeli Startup Develops AI Platform for Precise Genetic Drug Delivery

Israeli startup Undecimal Bio has created the DELiveri AI platform for precise delivery of genetic drugs to diseased cells, overcoming a key challenge in targeted therapy.

2 newsrooms · 1 language · since

Sign in to baba News

Sign in to save this article and find it on your phone.

or use an email code

By continuing you agree to the terms and privacy policy.

What happened

  1. 01Israeli startup Undecimal Bio created the DELiveri AI platform for precise genetic drug delivery.
  2. 02The platform uses AI and combinatorial chemistry to target diseased cells beyond the liver.
  3. 03This technology aims to overcome a major barrier in delivering genetic medications.
  4. 04The company raised $18 million in seed funding for clinical programs.
  5. 05Initial applications will target severe cardiovascular and kidney diseases.

The system uses machine learning and combinatorial chemistry to analyze molecular properties and optimize delivery to specific tissues, not just the liver. The company has raised $18 million in seed funding and will initially focus on treating cardiovascular and kidney diseases.

Translated and summarized by baba from Mignews, the latest report. Read Mignews’s original

The coverage

2 newsrooms on this story

Who covered it

  • LeftNone
  • CentreNone
  • RightNone
  • HarediNone
  • ArabNone
  • Other2

How it broke

See which of the 2 newsrooms broke it, and who waited